Attractive Market Opportunities in the Crude Oil Flow Improvers by 2025|Key Industry Participants Schlumberger, Nalco

San Francisco, 20 November 2018: The global crude oil flow improvers market is expected to reach USD 2.03 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to grow significantly over the forecast period owing to shale revolution positively affecting the COFI market. Despite several existing rigs being decommissioned over the last few years, the industry has witnessed an increase in the overall petroleum production. This has given an impetus to the need for utilization of these chemicals in the upstream extraction sector. 

The existence and expansion of product pipelines have encouraged the utilization of these products to improve the productivity, minimize the throughput time and eliminate the bottlenecks during the various operations across the oil and gas value chain. 

Asphaltene inhibitors are anticipated to be the fastest growing segment over the upcoming years and is projected to grow at a CAGR of 6.3% from 2017 to 2025. These products help to reduce the precipitation of asphaltenes, preserve the asset integrity of the flow lines and optimize the operations over the forecast period. The utility of these chemicals is predominant in the extraction and pipeline segments. The problems associated with the extraction and transportation of asphaltenic crude include pipeline deposition and wellbore plugging. These unwanted bottlenecks result in the increase in the demand for these products globally.

Paraffin inhibitors is expected to be the largest product segment. Paraffin content in crude oil can damage transport equipment. It helps in eradicating the effects of wax deposition during petroleum extraction, refining, and transportation.

Access Research Report of Crude Oil Flow Improvers Market @ www.grandviewresearch.com/industry-analysis/crude-oil-flow-improvers-cofi-market

Further key findings from the report suggest:

·       The global COFI market is estimated to grow at a CAGR of 5.6% from 2017 to 2025

·       Extraction is projected to emerge as the fastest application segment, predicted to grow at a CAGR of 6% from 2017 to 2025

·       Refinery application segment in Russia accounting for 24% in 2016 and is expected to witness a similar consumption trend over the forecast period

·       Asia Pacific accounted for over 14% of the global revenue in 2016 and is projected to grow at a CAGR of 6.3% from 2017 to 2025

·       UK asphaltene inhibitor was valued at USD 10.3 million in 2016 and is projected to grow at a CAGR of 5% over the projected period

·       Central & South American crude oil flow improvers market was valued at USD 104.9 million in 2016 and is anticipated to grow at a stable rate over the upcoming years

·       Major companies actively operating in the industry in the present scenario would include BASF, Halliburton, Schlumberger, Nalco, and Baker Huges.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the global crude oil flow improvers (COFI) market on the basis of application:

Crude Oil Flow Improvers Product Outlook (Revenue, USD Million, 2014 - 2025)

·         Paraffin Inhibitors

·         Asphaltene Inhibitors

·         Scale Inhibitors

·         Hydrate Inhibitors

Crude Oil Flow Improvers Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Extraction

·         Transportation

·         Refinery

Crude Oil Flow Improvers Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Central & South America (CSA)

·         Middle East & Africa

Access Press Release of Crude Oil Flow Improvers Market@ www.grandviewresearch.com/press-release/global-crude-oil-flow-improvers-cofi-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

3D Printing Metal Market to Grow at CAGR of 31.0% through 2025|Top Industry Players 3D Systems Corporation, Materialise NV

San Francisco, 20 November 2018: The global 3Dprinting metals market is expected to reach USD 2.86 billion by 2025, according to a new report by Grand View Research, Inc. Metals are the fastest growing 3D printing materials worldwide on account of high application scope coupled with increasing demand from the medical and dental application.

The market has witnessed advancements, both in terms of technologies and materials, in order to facilitate low cost and mass production of the products. This would also lead to flexibility in designs and ease of manufacturing of products for wide range of applications.

Numerous companies including GE have been utilizing metal 3D printing for the development of aerospace parts. In December 2016, Sigma Labs entered into a new contract with Honeywell aerospace. The Defense Advanced Research Project Agency (DARPA) selected the company for completion of phase III of the Open Manufacturing (OM) program. It is aimed at reducing the barriers involved in the metal 3D printing process including speed, cost, and repeatability.

Access Research Report of 3D Printing Metal Market@ www.grandviewresearch.com/industry-analysis/3d-metal-printing-market

Further key findings from the report suggest:

·       Powder segment is expected to witness the fastest CAGR of over 30% from 2016 to 2025 on account of significant technological development in the field of metal printers

·       Aerospace & defense sector dominated the industry in 2015 with a share of over 35% and is anticipated to witness significant growth on account of high application scope in military aircraft, aircraft engine, commercial aircraft, complex weapon systems, high volume weapons, and munition components

·       The medical sector accounted for a share of over 30%, in terms of revenue, in 2015 on account of increasing use of the technology in medical implants, medical devices, and surgical equipment including crowns & bridges, model castings, and abutments

·       Titanium is expected to witness rapid growth from 2016 to 2025 on account of superior mechanical properties, accuracy in production, and early adoption of the product in aerospace & defense and medical industry

·       Asia Pacific is anticipated to witness the fastest growth of over 30% from 2016 to 2025 on account of rapid industrial development, supportive government policies, and high R&D investment in China, Japan, and South Korea

·       New product development is one of the major strategies being adopted by the industry players in order to strengthen their global position

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/paints-coatings-and-printing-inks

Grand View Research has segmented the global 3D printing metals market on the basis of form, product, application, and region:

Form Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         Powder

·         Filament

Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         Titanium

·         Nickel

·         Steel

·         Aluminum

·         Others

Application Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         Aerospace & Defense

·         Automotive

·         Medical & Dental

·         Others

Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    Japan

·         Central & South America

o    Brazil

·         Middle East & Africa 

Access Press Release of 3D Printing Metal Market@ www.grandviewresearch.com/press-release/global-3d-metal-printing-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Hernia Mesh Devices Market is Expected to Reach $5.03 Billion by 2025| Key Industry Participants C. R. Bard, Inc.; Atrium Medical

San Francisco, 20 November 2018: The global herniamesh devices market is expected to reach USD 5.03 billion by 2025, based on a new report by Grand View Research, Inc. The market is expected to grow over the forecast period owing to increase in incidence of hernia, high adoption of meshes in surgeries due to factors such as cost-effectiveness, reduced pain, reduced operative time, and high availability of products in the market. 

The reimbursement scenario for hernia mesh is favorable, which encourages patients to opt for open or laparoscopic surgery. Patients have easy access to detailed reimbursement codes and ratios, which are made available by government and industry players. The codes are granulated to types of hernias, (primary or recurrent) and method of surgery (open or laparoscopic).

Furthermore, technological advancements and new products introduction, such as TELA Bio, are driving the overall market growth. In 2010, PROCEED Ventral Patch (PVP) device was launched by Ethicon for the treatment of umbilical hernia. In 2016, GORE SYNECOR biomaterial, a product of W. L. Gore & Associates, was approved by FDA as a repair solution for ventral hernia.

Access Research Report of Hernia Mesh Devices Market@ www.grandviewresearch.com/industry-analysis/hernia-mesh-devices-market

Further Key Findings from the Study Suggest:

·       Biological surgical meshes is the fastest growing segment owing to high price of the products and increased preference for these products by healthcare professionals and patients

·       In February 2016, an EU-funded Green Nano Mesh was launched for bio-based, eco-friendly treatment of hernia that would cause less harm to patients

·       Geographically, North America held the largest market share in 2016 and is expected to maintain its position during the forecast period. Factors responsible for the large market share are high incidence of the target disorder and high adoption of surgical meshes as a treatment option

·       Asia Pacific is also expected to witness rapid growth over the forecast period. Growing awareness about the target disorder and improved access to healthcare drives the growth in this region

·       The 13th International Congress of Asia Pacific Hernia Society is intended to be held in China in September 2017

·      Some of the key players in the hernia mesh market are Medtronic; Ethicon, Inc., C. R. Bard, Inc.; Atrium Medical; and B. Braun Melsungen AG.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the hernia mesh devices market by hernia type, mesh type and region:

Hernia Type Outlook (Revenue, USD Million; 2014 - 2025)

·         Inguinal Hernia

·         Incisional Hernia

·         Femoral Hernia

·         Others

Mesh Type Outlook (Market Revenue in USD Million, 2014 - 2025)

·         Biologic Mesh

·         Synthetic Mesh

Regional Outlook (Market Revenue in USD Million, 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East and Africa

Access Press Release of Hernia Mesh Devices Market@ www.grandviewresearch.com/press-release/global-hernia-mesh-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Prostate Cancer Therapeutics Market to Surpass $12.0 Billion by 2025|Key Industry Participants Sanofi; Ipsen; Bayer AG

San Francisco, 20 November 2018: The global prostate cancer therapeutics market is expected to reach USD 12.0 billion by 2025, according to a new report by Grand View Research, Inc. According to the American Cancer Society, approximately 1 in 7 men will be diagnosed with prostate cancer in their lifetime. As per Cancer Research, a government institute, in the UK, 46,690 new cases of prostate cancer were diagnosed out of which 11,287 patients died in 2014.

Supportive initiatives undertaken by key players in collaboration with various governments to create more awareness of clinical symptoms about prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Early detection helps in quick and on time treatment and assists in deciding treatment regimens. In addition, major players including Astella, Inc., Sanofi, Dendreon Corporation, AstraZeneca, and Johnson & Johnson are focusing on development of effective and safe therapeutic products to treat tumor. Moreover, these players have various established brands such as Zytiga, Xtandi, Eligard, Taxotere, Provenge, and Xofigo, which hold a strong position in the market. In addition, there are many drugs in pipeline such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), and ODM-201 (Orion and Bayer), which are in their phase 3 studies and are expected to enter the market during the forecast period. In addition, patents of many existing products are expiring during the forecast period. As a result, generic products are anticipated to penetrate the market. All these factors together are expected to propel growth.

In Canada, Prostate Cancer Foundation of Canada supports research, cure, and prevention of prostate cancer through an online portal. This portal provides detailed information regarding symptoms, diagnosis, and commercially available treatment options. Such portals offer free access to people all around the world, which is resulting in growth.

Access Research Report of Prostate Cancer Therapeutics Market @ www.grandviewresearch.com/industry-analysis/prostate-cancer-therapeutics-market

Further key findings from the study suggest:

·       The growing incidence of prostate cancer across the globe is expected to drive growth

·       The market is segmented into hormonal therapy including Luteinizing Hormone Releasing Hormone (LHRH) agonist, LHRH antagonist & antiandrogen; chemotherapy; immunotherapy, and targeted therapy

·       Zytiga (Johnson & Johnson) is considered as a gold standard product for the treatment of prostate cancer and holds a strong position. However, Xtandi (Astella, Inc.) and Zytiga are competing with each other. The degree of competition is projected to elevate during the forecast period. Thus, hormonal therapy holds the largest share.

·       Provenge (Dendreon Corporation) is the only immunotherapy drug mainly used in the treatment of advanced or metastasis of such cancerous cells

·       In addition, there are many promising immunotherapy drugs in the pipeline such as INO-5150 SynCon and PROSTVAC (Bavarian Nordic), which are expected to enter the market in the near future. Thus, this drug class is projected to be the fastest growing segment.

·       North America dominated the global market. Rising prevalence and mortality rate associated with such tumors in the U.S. is the primary reason for the dominance of the region.

·       Asia Pacific is anticipated to be the fastest growing region over the forecast period. Rising awareness regarding prostate cancer in Asian countries including China, Japan, & India, would be the major factor driving the growth.

·       Some of the major players include, but are not limited to, Johnson & Johnson; Astella, Inc.; Sanofi; Ipsen; Bayer AG; AstraZeneca; Valeant Pharmaceuticals North America LLC (Dendreon Corporation). These major players dominate the market owing to their strong brand identity and extensive geographic reach.

Browse more reports of this category by Grand View Research at: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the prostate cancer therapeutics market by drug and region:

Drugs Outlook (Revenue, USD billion; 2014 - 2025)

·         Hormonal Therapy

o    Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists

o    Luteinizing Hormone-Releasing Hormone (LHRH) Agonists

o    Anti-Androgen

o    Chemotherapy

o    Immunotherapy

o    Targeted Therapy

Regional Outlook (Revenue, USD billion; 2014 - 2025)

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         MEA

Access Press Release of Prostate Cancer Therapeutics Market@ www.grandviewresearch.com/press-release/global-prostate-cancer-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com